 "Natco Pharma Q4 PBT down 23% at Rs 117 cr on decline in Hep C portfolio")
Hyderabad-based Natco Pharma Limited has reported a 23.43 per cent decline in consolidated profit before tax (PBT) at Rs 116.7 crore for the quarter ended March 31, 2020 as compared to Rs 152.4 crore in the corresponding quarter previous year. Total income for the quarter under review declined marginally to Rs 477.2 crore from Rs 486.7 crore in the year ago period.
For the full year ended March 31, 2020 the PBT stood at Rs 568.7 crore, a 31 per cent decline over Rs 824.7 crore in the previous year. Total income for the year was down nine per cent at
